Enanta Pharmaceuticals Inc.

NASDAQ: ENTA
Share price (12/24/24): $6.10
Market cap (12/24/24): $129 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 FY 2024

ended 06/30/24 Q3

ended 03/31/24 Q2

ended 12/31/23 Q1

ended 09/30/23 FY 2023

Prospectuses and Registrations Filter

Registration of securities for employees

Shelf registration

Post-effective amendment to an automatic shelf registration

Registration of securities for employees

Prospectus supplement for primary offering

Ownership Filter

Kieffer Tara Lynn

Rottinghaus Scott T.

News Filter

Announces Positive Topline Results From First-In-Pediatrics Phase 2 Study Evaluating Zelicapavir for the Treatment of Respiratory Syncytial Virus

Reports Financial Results for Its Fiscal Fourth Quarter and Year-Ended September 30, 2024

Reports Financial Results for Its Fiscal Third Quarter

Reports Financial Results for Its Fiscal Second Quarter With Webcast and Conference Call Today at 4:30 p.m. ET

Change in Directors, Officers or Compensation, Shareholder Vote Results, Financial Statements or Exhibits

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Letter from the SEC

Correspondence with the SEC

Notice of effectiveness

Letter from the SEC

Correspondence with the SEC